Literature DB >> 6595667

Necrosin: purification and properties of a cytotoxin derived from a murine macrophage-like cell line.

F C Kull, P Cuatrecasas.   

Abstract

An acidic proteinaceous cytotoxin was isolated from the serum-free, cell-free supernatants of J774.1 (a murine macrophage-like line) cells that had been treated with bacterial endotoxin. Cytotoxic activity was routinely monitored using the sensitive murine tumorigenic fibroblast line L-M. The toxin was purified 8000-fold by ion-exchange and electrophoretic procedures. It was purified to greater than 90% homogeneity, as assessed by photometric scanning of silver-stained NaDodSO4/polyacrylamide gels. The specific activity of the purified toxin was 32,000 units/microgram. The toxin was composed of self-aggregating non-sulfhydryl-linked multimers of a Mr 15,000 subunit. The pI of the monomer was 4.6. The active multimeric forms, as assessed by gel filtration and assayed using L-M cells, were of Mr 70,000 and 55,000. These forms were identical to those observed both in crude supernatants and in purified fractions that had not been subjected to denaturing agents. We call these forms "holotoxins" and conclude that they are aggregates of the Mr 15,000 protein. The purified toxin (1-1000 pM, 0.06-60 ng/ml) was active against a random assortment of tumorigenic and normal cell lines of murine, bovine, and human origin. For example, the diploid bovine endothelial line CPAE was nearly as sensitive as the L-M line. Similarities to other toxic macrophage products, lymphotoxin, and tumor necrosis factor are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6595667      PMCID: PMC392267          DOI: 10.1073/pnas.81.24.7932

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Interferoids: in vitro and in vivo conversion of native interferons to lower molecular weight forms.

Authors:  W E Stewart; T Chudzio; L S Lin; M Wiranowska-Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Identification and initial characterization of a nonspecific suppressor factor (macrophage-SF) produced by soluble immune response suppressor (SIRS)-treated macrophages.

Authors:  T M Aune; C W Pierce
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

4.  Molecular weight of human gamma interferon is similar to that of other human interferons.

Authors:  Y K Yip; B S Barrowclough; C Urban; J Vilcek
Journal:  Science       Date:  1982-01-22       Impact factor: 47.728

5.  Human lymphotoxin. Production by a lymphoblastoid cell line, purification, and initial characterization.

Authors:  B B Aggarwal; B Moffat; R N Harkins
Journal:  J Biol Chem       Date:  1984-01-10       Impact factor: 5.157

6.  Isolation of microgram quantities of proteins from polyacrylamide gels for amino acid sequence analysis.

Authors:  M W Hunkapiller; E Lujan; F Ostrander; L E Hood
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

7.  Possible requirement of internalization in the mechanism of in vitro cytotoxicity in tumor necrosis serum.

Authors:  F C Kull; P Cuatrecasas
Journal:  Cancer Res       Date:  1981-12       Impact factor: 12.701

8.  Partial purification of a serum factor that causes necrosis of tumors.

Authors:  S Green; A Dobrjansky; E A Carswell; R L Kassel; L J Old; N Fiore; M K Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

9.  Possible importance of macrophage-derived mediators in acute malaria.

Authors:  I A Clark; J L Virelizier; E A Carswell; P R Wood
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

10.  Tumour-necrosis factor from the rabbit. V. Synthesis in vitro by mononuclear phagocytes from various tissues of normal and BCG-injected rabbits.

Authors:  N Matthews
Journal:  Br J Cancer       Date:  1981-09       Impact factor: 7.640

View more
  12 in total

1.  Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.

Authors:  M Fràter-Schröder; W Risau; R Hallmann; P Gautschi; P Böhlen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

2.  Suppression of both macrophage-mediated tumor cell lysis and cytolytic factor production by a factor (CIF) derived from normal embryonic fibroblasts.

Authors:  R Gallily; G E Gifford; J Loewenstein
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Correlation between the synergistic effect of liposomes and endotoxins on the activation of macrophage tumoricidal activity and the effect of liposomes on the rough endoplasmic reticulum of macrophages.

Authors:  J F Jeannin; R Klein; D Reisser; P Lagadec; M Vincent; I Tatischeff
Journal:  J Membr Biol       Date:  1988-09       Impact factor: 1.843

4.  Effects of injection routes of growing tumors and PSK or OK-432 on antiproliferative activity of mouse serum.

Authors:  C Ryoyama; K Ryoyama
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor.

Authors:  D Pennica; J S Hayflick; T S Bringman; M A Palladino; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

6.  Purification, characterization, and antitumor activity of nonrecombinant mouse tumor necrosis factor.

Authors:  K Haranaka; E A Carswell; B D Williamson; J S Prendergast; N Satomi; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

7.  Regulation of transcription factor mRNA accumulation during 3T3-L1 preadipocyte differentiation by antagonists of adipogenesis.

Authors:  J M Stephens; M Butts; R Stone; P H Pekala; D A Bernlohr
Journal:  Mol Cell Biochem       Date:  1993 Jun 9-23       Impact factor: 3.396

8.  Tumor necrosis factor: recent advances.

Authors:  R Munker; H P Koeffler
Journal:  Klin Wochenschr       Date:  1987-04-15

9.  Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity.

Authors:  F C Kull; S Jacobs; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

10.  Use of monoclonal antibodies to a human cytotoxin for its isolation and for examining the self-induction of resistance to this protein.

Authors:  T Hahn; L Toker; S Budilovsky; D Aderka; Z Eshhar; D Wallach
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.